• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

NLT Spine

SeaSpine acquisition of NLT Spine could be worth $53m

August 19, 2016 By Brad Perriello

SeaSpine (NSDQ:SPNE) said yesterday that it agreed to acquire Israeli firm NLT Spine in a deal that could wind up being worth $52.5 million. Kfar Saba, Israel-based NLT makes a line of minimally invasive spinal implants for lumbar fusion procedures that are designed to expand after implantation. The deal with Carlsbad, Calif.-based SeaSpine, which spun out of Integra […]

Filed Under: Mergers & Acquisitions, Orthopedics, Spine, Wall Street Beat Tagged With: NLT Spine, SeaSpine

Aptus Endosystems lands FDA nod for abdominal aneurysm device

September 20, 2012 By MassDevice staff Leave a Comment

Aptus Endosystems lands FDA nod for abdominal aneurysm device

Filed Under: 510(k), News Well Tagged With: Aptus EndoSystems Inc., Intelomed, K2M, NLT Spine, Opto Circuits Ltd., SuperSonic Imagine S.A.

Abbott wins FDA nod for next-gen cataract laser | Regulatory Roundup

April 20, 2012 By MassDevice staff Leave a Comment

MassDevice.com Regulatory Roundup

 Abbott gets FDA nod for advanced femtosecond laser for cataract surgery

Filed Under: 510(k), News Well Tagged With: Abbott, Bayer, Carestream Health Inc., Devicor Medical Products, Isansys, ITGI Medical Ltd., Neurometrix, NLT Spine, Regulatory Roundup, Revolutions Medical Corp., stjudemedical, Tengion Inc.

“Exit hangover” casts a pall on private equity | Wall Street Beat

March 6, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Private equity players are in for some stiff competition this year, as large-cap PE shops invade the middle-market space, according to a report from PE stalwart Bain & Co.

The company’s Global PE Report details a huge “exit overhang” – more aptly deemed an “exit hangover” by PE Hub’s Jonathan Marino – as PE-backed companies seek exits.

And the mega-deals of the past 10 years or so are a thing of the past, according the report, as detailed by Marino.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Baxter, Boston Life Labs, Cambridge Heart Inc., EndoChoice, Health Robotics, Interactive Optics, MAKO Surgical Corp., NantWorks, Natus Medical Inc., NLT Spine, Premier Inc., SeraCare Life Sciences Inc., Stereotaxis, Venture Capital/Private Equity

St. Jude lands FDA win for 2 next-gen cardiac ablation catheters | Regulatory Roundup

February 6, 2012 By MassDevice staff Leave a Comment

St. Jude's ablation systems

St. Jude Medical Inc. (NYSE:STJ) won pre-market approval for 2 next-generation cardiac ablation systems this month, the Therapy Cool Path Duo and Safire Blu Duo catheters.

Both ablation systems use radiofrequency energy to freeze small areas of faulty cardiac tissue in patients with typical trial flutter, a type of arrhythmia in which patients experience abnormal heart rhythms or an abnormally fast heartbeat in the upper chambers of the heart.

Filed Under: Catheters, News Well Tagged With: Ablation, Cook Medical, ETView, Hitachi Medical Systems America, Horizon Medical Services, Intuitive Surgical, Medi-tate Ltd., MindChild Medical Inc., Navidea Biopharmaceuticals, NLT Spine, SenoSense Medical Systems Inc., stjudemedical

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy